Rein Therapeutics (RNTX) Common Equity (2016 - 2026)
Rein Therapeutics' Common Equity came in at $55.2 million for Q2 2026, up 15.0% from $48.01 million a year earlier and up 376.3% from the prior quarter.
Powered by 
Analysis
Rein Therapeutics (RNTX) Common Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, Rein Therapeutics' Common Equity was $16.92 million, down 68.9% from FY2024.
- Common Equity carries a five-year compound annual growth rate of 6.8% (FY2020 to FY2025).
- Going back by year, Common Equity was $54.39 million in FY2024 (-44.7%), $98.3 million in FY2023 (+427.8%), $18.62 million in FY2022 (-57.6%) and $43.9 million in FY2021 (+261.0%).
- The Q2 2026 figure represents the highest quarterly Common Equity since Q3 2024.
- Year-over-year, Common Equity increased in two of the last eight quarters, with growth averaging 53.2%.
- The fastest year-over-year change in Common Equity over five years came in Q3 2024 (growth of 750.4%), and the weakest in Q1 2026 (a decline of 76.8%).
- Business Quant data shows RNTX's Common Equity at $11.59 million (Q1 2026), $16.92 million (Q4 2025) and $46.19 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Rein Therapeutics | 48.30 Mn | 48.30 Mn | - | 55.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.20 Mn |
| Mar 31, 2026 | 11.59 Mn |
| Dec 31, 2025 | 16.92 Mn |
| Sep 30, 2025 | 46.19 Mn |
| Jun 30, 2025 | 48.01 Mn |
| Mar 31, 2025 | 49.88 Mn |
| Dec 31, 2024 | 54.39 Mn |
| Sep 30, 2024 | 95.23 Mn |
| Jun 30, 2024 | 101.02 Mn |
| Mar 31, 2024 | 91.33 Mn |
| Dec 31, 2023 | 98.30 Mn |
| Sep 30, 2023 | 11.20 Mn |
| Jun 30, 2023 | 12.79 Mn |
| Mar 31, 2023 | 14.27 Mn |
| Dec 31, 2022 | 18.62 Mn |
| Sep 30, 2022 | 22.70 Mn |
| Jun 30, 2022 | 28.62 Mn |
| Mar 31, 2022 | 36.11 Mn |
| Dec 31, 2021 | 43.90 Mn |
| Sep 30, 2021 | 50.11 Mn |
API Access
Rein Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();